Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Xiaofang, Che"'
Autor:
Jia Guo, Xin Sun, Guowei Pan, Ce Li, Xin He, Xiaofang Che, Zan Teng, Xiujuan Qu, Yunpeng Liu, Bowen Yang
Publikováno v:
Genes and Diseases, Vol 11, Iss 2, Pp 568-570 (2024)
Externí odkaz:
https://doaj.org/article/3dc0228122d14765899db3035916c62a
Autor:
Yang Chen, Hongfei Yan, Lirong Yan, Ximing Wang, Xiaofang Che, Kezuo Hou, Yi Yang, Xuena Li, Yaming Li, Ye Zhang, Xuejun Hu
Publikováno v:
Cell Death and Disease, Vol 14, Iss 9, Pp 1-11 (2023)
Abstract Aldehyde dehydrogenase 3A1 (ALDH3A1) is an NAD+-dependent enzyme that is closely related to tumor development. However, its role in non-small-cell lung cancer (NSCLC) has not been elucidated. This study aimed to clarify the mechanism of ALDH
Externí odkaz:
https://doaj.org/article/b542ac49a8c546d4a439957a41f9c142
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/b5d185cebc734955b56a6d7aa1f12792
Autor:
Jie Wu, Chunlei Zheng, Yizhe Wang, Zichang Yang, Ce Li, Wanxia Fang, Yue Jin, Kezuo Hou, Yang Cheng, Jianfei Qi, Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Xuejun Hu
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/c4392cc1a5b74d0aa77743c3d791fc92
Autor:
Jie Wu, Chunlei Zheng, Yizhe Wang, Zichang Yang, Ce Li, Wanxia Fang, Yue Jin, Kezuo Hou, Yang Cheng, Jianfei Qi, Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Xuejun Hu
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-17 (2021)
Abstract Background Epidermal growth factor receptor-tyrosinase kinase inhibitor (EGFR-TKI) resistance is the major obstacle in the treatment of lung adenocarcinoma (LUAD) patients harboring EGFR-sensitive mutations. However, the long non-coding RNAs
Externí odkaz:
https://doaj.org/article/d0c4a1b3e17447dc96c07e9a6b8da4f1
Autor:
Xiaoxun Wang, Xiaofang Che, Yang Yu, Yu Cheng, Ming Bai, Zichang Yang, Qiqiang Guo, Xiaochen Xie, Danni Li, Min Guo, Kezuo Hou, Wendong Guo, Xiujuan Qu, Liu Cao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-14 (2020)
Abstract Background Peritoneal metastasis (PM) is an important pathological process in the progression of gastric cancer (GC). The metastatic potential of tumor and stromal cells is governed by hypoxia, which is a key molecular feature of the tumor m
Externí odkaz:
https://doaj.org/article/025affd0436940318f6433dd944f1209
Autor:
Xiaonan Shi, Libao Gong, Yunpeng Liu, Kezuo Hou, Yibo Fan, Ce Li, Ti Wen, Xiujuan Qu, Xiaofang Che
Publikováno v:
Epigenetics, Vol 15, Iss 6-7, Pp 632-645 (2020)
Histone acetylation is regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs). It is associated with gene transcription and expression. 4-Phenylbutyric acid (4-PBA), an HDAC inhibitor (HDACi), can inhibit cancer cell prolifer
Externí odkaz:
https://doaj.org/article/83d64ea42a1f4afba7baa08f7ddec43f
Autor:
Wanxia Fang, Xiaofang Che, Guohui Li, Anhui Wang, Yizhe Wang, Xiaonan Shi, Kezuo Hou, Xiaojie Zhang, Xiujuan Qu, Yunpeng Liu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-18 (2020)
Abstract Background Survivin and XIAP are two important members of the inhibitor of apoptosis protein family and have been considered as potential targets for cancer treatment due to their overexpression in large variety of cancers including colorect
Externí odkaz:
https://doaj.org/article/d7416ac07501445fab9ecdbd518f0bb9
Autor:
Xing Wan, Yongxi Song, Honghong Fang, Ling Xu, Xiaofang Che, Shuo Wang, Xiaomeng Zhang, Lingyun Zhang, Ce Li, Yibo Fan, Kezuo Hou, Zhi Li, Xueqing Wang, Yunpeng Liu, Xiujuan Qu
Publikováno v:
Clinical and Translational Medicine, Vol 9, Iss 1, Pp 1-9 (2020)
Abstract Background The incidence and mortality rates of gastric cancer (GC) rank in top five among all malignant tumors. Chemokines and their receptor-signaling pathways reportedly play key roles in the metastasis of malignant tumor cells. Receptor
Externí odkaz:
https://doaj.org/article/ca7d68902dc94631ab73be223120a716
Autor:
Yue Jin, Xiaofang Che, Xiujuan Qu, Xin Li, Wenqing Lu, Jie Wu, Yizhe Wang, Kezuo Hou, Ce Li, Xiaojie Zhang, Jianping Zhou, Yunpeng Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/516b8cb605814a9bb6c169374cc3f27b